Oklahoma Returns Hydroxychloroquine Stockpile For Refund
Oklahoma officials announced they have returned the state’s stockpile of hydroxychloroquine. The drug, which former President Donald Trump touted for its potential to treat COVID-19, is on its way back to the manufacturer.
At the beginning of the pandemic, the U.S. Food and Drug Administration approved hydroxychloroquine to treat COVID-19. The medication became a household name once Donald Trump hailed it as a game changer. Despite controversy at the time, Oklahoma health officials bought $2 million worth of doses and built a stockpile. The FDA soon revoked the approval; regulators found the drug to be not only ineffective but in some cases dangerous.
Attorney General Mike Hunter announced Friday that his office had reached an agreement with the drug’s manufacturer for a full refund.